MFA
Mayflower Financial Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Sell |
15,684
-51
| -0.3% | -$9.47K | 0.41% | 61 |
|
|
2025
Q1 | $3.3M | Buy |
15,735
+83
| +0.5% | +$17.4K | 0.5% | 50 |
|
|
2024
Q4 | $2.78M | Sell |
15,652
-342
| -2% | -$60.8K | 0.42% | 58 |
|
|
2024
Q3 | $3.16M | Sell |
15,994
-224
| -1% | -$44.2K | 0.48% | 53 |
|
|
2024
Q2 | $2.78M | Sell |
16,218
-34
| -0.2% | -$5.83K | 0.46% | 56 |
|
|
2024
Q1 | $2.96M | Sell |
16,252
-78,439
| -83% | -$14.3M | 0.49% | 51 |
|
|
2023
Q4 | $14.7M | Sell |
94,691
-489
| -0.5% | -$75.8K | 2.03% | 9 |
|
|
2023
Q3 | $14.2M | Sell |
95,180
-1,960
| -2% | -$292K | 2.12% | 8 |
|
|
2023
Q2 | $13.1M | Buy |
97,140
+683
| +0.7% | +$92.2K | 1.7% | 13 |
|
|
2023
Q1 | $15.4M | Buy |
96,457
+283
| +0.3% | +$45.1K | 2.02% | 9 |
|
|
2022
Q4 | $15.5M | Buy |
96,174
+1,099
| +1% | +$178K | 2.16% | 9 |
|
|
2022
Q3 | $12.8M | Buy |
95,075
+292
| +0.3% | +$39.2K | 2.06% | 11 |
|
|
2022
Q2 | $14.5M | Sell |
94,783
-769
| -0.8% | -$118K | 2.22% | 9 |
|
|
2022
Q1 | $15.5M | Buy |
95,552
+279
| +0.3% | +$45.2K | 2.08% | 11 |
|
|
2021
Q4 | $12.9M | Buy |
95,273
+1,623
| +2% | +$220K | 1.71% | 13 |
|
|
2021
Q3 | $10.1M | Buy |
93,650
+172
| +0.2% | +$18.5K | 1.36% | 16 |
|
|
2021
Q2 | $10.5M | Sell |
93,478
-50
| -0.1% | -$5.63K | 1.45% | 17 |
|
|
2021
Q1 | $10.1M | Buy |
93,528
+339
| +0.4% | +$36.7K | 1.5% | 18 |
|
|
2020
Q4 | $9.99M | Buy |
+93,189
| New | +$9.99M | 1.72% | 16 |
|